Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Sep-05-21 |
| | 10-Q | 10-K | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K |
| Revenues: |
| Product Sales | | 6.4 | | 7.2 | 7.5 | | 6.2 | |
| Other | | 0.1 | | 0.1 | 0.1 | | 0.4 | |
| In Vitro Diagnostics revenues | 5.9 | 6.5 | | 7.3 | 7.7 | 6.1 | 6.6 | |
| Revenue growth [+] | -3.0% | -1.3% | | 2.9% | 8.0% | -0.1% | 22.6% | |
| Product Sales | | 3.8% | | 8.9% | 18.0% | | 18.7% | |
| EBITDA | 3.0 | 2.9 | | 3.5 | 3.8 | 3.2 | 3.4 | |
| EBITDA margin | 51.1% | 44.8% | | 47.4% | 49.7% | 53.2% | 52.4% | |
| Depreciation and amortization | 0.1 | 0.1 | | 0.1 | 0.1 | 0.1 | 0.1 | |
| EBIT | 2.9 | 2.8 | | 3.4 | 3.7 | 3.2 | 3.4 | |
| EBIT margin | 49.8% | 43.3% | | 46.2% | 48.6% | 51.8% | 51.1% | |
| |
| Revenue Mix | 23.7% | 25.0% | | 29.5% | 29.3% | 26.5% | 27.4% | |
| EBIT Mix | | | | | | | | |
|